Resultados de la búsqueda 151-160 of 8449 for Custom Birth Control
... control (HC) donors. Registry for the EVolution Of LUng Cancer Therapy ... population. Patients will be enrolled over a three year period across ...
... population. Patients will be enrolled over a three year period across ... control (HC) donors. Alternate Doses and Dosing Schedules of Belantamab ...
... controls without history of cancer. Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis. Jacksonville, Fla. This is a prospective, pilot ...
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...
The results of this trial will provide a foundation for the future development of larger definitive randomized controlled trials. Patients with solid ...
The purpose of this multicenter prospective observational case-control study is to train and validate Adela's cfMeDIP-seq based methylome profiling platform to ...
... population. Patients will be enrolled over a three year period across approximately 25 geographically diverse academic as well as community based sites ...
... control animals. Analysis of the Cardiac, Aorta and Carotid Artery Walls for Hemodynamic Monitoring in the Intensive Care Unit. Jacksonville, Fla. The ...
Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad y experiencia en el control de ...
Rochester, Minn. This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?